Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 21121053)

1.

Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participants.

Grady BJ, Torstenson ES, McLaren PJ, DE Bakker PI, Haas DW, Robbins GK, Gulick RM, Haubrich R, Ribaudo H, Ritchie MD.

Pac Symp Biocomput. 2011:253-64.

2.

Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV.

Cruciani M, Mengoli C, Serpelloni G, Parisi SG, Malena M, Bosco O.

Cochrane Database Syst Rev. 2013 Jun 5;6:CD008270. doi: 10.1002/14651858.CD008270.pub2. Review.

PMID:
23740608
3.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
4.

Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.

Chang LW, Harris J, Humphreys E.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Review.

PMID:
20393969
5.

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.

Mbuagbaw LC, Irlam JH, Spaulding A, Rutherford GW, Siegfried N.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD004246. doi: 10.1002/14651858.CD004246.pub3. Review.

PMID:
21154355
7.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
8.

Efavirenz: a decade of clinical experience in the treatment of HIV.

Maggiolo F.

J Antimicrob Chemother. 2009 Nov;64(5):910-28. doi: 10.1093/jac/dkp334. Epub 2009 Sep 18. Review.

9.

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Sangani PR, Kennedy GE.

Cochrane Database Syst Rev. 2003;(4):CD002037. Review.

PMID:
14583945
10.

Efavirenz: a review.

Vrouenraets SM, Wit FW, van Tongeren J, Lange JM.

Expert Opin Pharmacother. 2007 Apr;8(6):851-71. Review.

PMID:
17425480
11.

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.

Sturt AS, Dokubo EK, Sint TT.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Review.

PMID:
20238370
12.

Efavirenz.

Maggiolo F.

Expert Opin Pharmacother. 2007 Jun;8(8):1137-45. Review.

PMID:
17516877
13.
14.

The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.

Michaud V, Bar-Magen T, Turgeon J, Flockhart D, Desta Z, Wainberg MA.

Pharmacol Rev. 2012 Jul;64(3):803-33. doi: 10.1124/pr.111.005553. Review.

15.

Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults.

Siegfried NL, Van Deventer PJ, Mahomed FA, Rutherford GW.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004535. Review.

PMID:
16625606
16.

Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS.

Shey MS, Kongnyuy EJ, Alobwede SM, Wiysonge CS.

Cochrane Database Syst Rev. 2013 Mar 28;3:CD005481. doi: 10.1002/14651858.CD005481.pub3. Review.

PMID:
23543540
17.

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.

Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Kozal MJ, Hullsiek KH, Miller MD, Bangsberg DR, Kuritzkes DR.

AIDS. 2012 Jan 14;26(2):185-92. doi: 10.1097/QAD.0b013e32834e9d7d. Review.

18.

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Feldman KA, Kennedy GE.

Cochrane Database Syst Rev. 2000;(2):CD002037. Review. Update in: Cochrane Database Syst Rev. 2003;(4):CD002037.

PMID:
10796850
19.

Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: an update.

Cressey TR, Lallemant M.

Infect Genet Evol. 2007 Mar;7(2):333-42. Epub 2006 Oct 11. Review.

PMID:
17045554
20.

Analysis pipeline for the epistasis search - statistical versus biological filtering.

Sun X, Lu Q, Mukherjee S, Crane PK, Elston R, Ritchie MD.

Front Genet. 2014 Apr 30;5:106. doi: 10.3389/fgene.2014.00106. eCollection 2014. Review. Erratum in: Front Genet. 2014;5:350. Mukheerjee, Shubhabrata [corrected to Mukherjee, Shubhabrata].

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk